DNA Diagnostics Market: Huge Growth Opportunities | Industry Trends | Market Analysis & Global Forecast to 2020

The global DNA Diagnostic Market would generate $19 billion by 2020, growing at a CAGR of 9.8% from 2014 to 2020. The report offers detailed analysis of key segments, changing market dynamics, key winning strategies, competitive scenario, and regions.

Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/298?utm_source=openpr&utm_medium=Niranjan

The latest figures suggest that approximately 8.2 million people are living with cancer and 39 million with HIV. These numbers are set to increase consistently; however, advanced automated DNA diagnostics technologies such as next generation sequencing could play a crucial role in diagnosing and curbing these diseases. “Next generation sequencing has had a significant impact on diagnostic procedures and is set to gain momentum in the foreseeable future.

Rise in incidence of infectious & chronic diseases, advancements in technology, and rise in popularity of personalized medicines drive the growth in the global DNA diagnostics industry. However, high costs related to research & development activities and stringent government regulations restrain the growth in the market. Innovations in product design and technology along with improvement in healthcare infrastructure would create new opportunities in the industry.

The report offers a detailed segmentation of the global DNA diagnostics market based on product type, technology, application, and geography. Product types analyzed in the research include reagents, instruments, and service & software. The instruments segment contributed for the major share in the market, owing to availability of user-friendly instruments, improved healthcare infrastructure, and competitive cost structure. However, the service & software segment would register the highest CAGR during the forecast period, owing to technological advancements and utilization of information technology solutions. Based on technology, the report bifurcates the market into PCR, sequencing technology, mass spectrometry, in-situ hybridization, and microarrays. PCR held the highest market share due to its adoption in diagnostic procedures such as separation, sample preparation, and isolation of DNA from samples.

Purchase Inquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/298?utm_source=openpr&utm_medium=Niranjan

Applications analyzed into the report include infectious diseases, oncology, and myogenic disorders. The oncology segment accounted for the highest share and will continue to dominate owing to increase in incidence of these diseases and rise in aging population. Geographically, the market is bifurcated into North America, Europe, Asia Pacific, and LAMEA. North America dominates the market owing to rise in adoption of the DNA diagnostics technology and prevalence of chronic and infectious diseases.

Market analysis in terms of geography suggests that developed economies would retain their dominance in the market. This could be attributed to the early adoption of the technology due to potential reduction offered by DNA diagnostic to their high healthcare expenditure. However, developing economies, such as in Asia-Pacific, will significantly influence the DNA diagnostic market during the extended forecast period (2020-2025), largely due to potential growth in per capita healthcare expenditure and very large undiagnosed population.

Several companies operating in this region are seeking novel technologies to gain traction in the competitive market. Product launch is the key strategy adopted by companies operating in this market. These companies are developing novel products for the treatment of various diseases such as infectious diseases, cancer, prenatal diagnosis, pre-implantation diagnostics and myogenic disorder. Additionally, these companies are also adopting collaboration and acquisition to retain their respective positions and to gain traction in the market.

Companies analyzed in the report include Roche Diagnostics, Sysmex, Bayer Diagnostic, Gene-probe Inc., Abbott laboratories, Illumina, Inc., Cephide, Thermo Fisher Scientific, Bio-Rad Laboratories, Johnson and Johnson, and Novartis. They have adopted various strategies including partnerships, expansions, mergers & acquisitions, joint ventures, collaborations, and others to strengthen their position in the industry.

About Us:-

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact Us:-

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.